BioCentury | Jan 21, 2021
Product Development

The evolving zeitgeist of COVID-19 testing

Becoming an essential pillar of the pandemic response has pushed the diagnostics industry toward more rapid and decentralized technologies, with a greater focus on routine asymptomatic screening. One year...
BioCentury | Nov 17, 2020
Product Development

Moderna times & China’s future: a BioCentury podcast

...sterilizing immunity, which is to say that somebody who gets vaccinated then can no longer transmit...
BioCentury | Oct 7, 2020
Product Development

Antigen tests outshine PCR at predicting who can transmit SARS-CoV-2

A new study finds antigen tests for COVID-19 do a better job of predicting which patients are infectious than PCR tests, even though the latter tend to be more sensitive. That conclusion, which came in...
BioCentury | Sep 19, 2020
Politics, Policy & Law

What it will take to get to mass asymptomatic screening for COVID-19

Making widespread COVID-19 screening a priority for public health will require a broad and abundant basket of testing technologies, and a coordinated plan for how to use and pay for them. The first barrier...
BioCentury | Sep 9, 2020
Product Development

NIH’s Pérez-Stable outlines ways biopharmas can address racial disparities in healthcare: a BioCentury audio interview

Eliseo Pérez-Stable, director of NIH’s National Institute on Minority Health and Health Disparities, says the information on racial and minority ethnic disparities in healthcare is out there, it’s...
BioCentury | Sep 2, 2020
Product Development

COVID-19 Quick Takes: NAS framework on vaccine allocation prioritizes higher risk groups

Framework to allocate vaccinesA discussion draft of a framework on equitable allocation of COVID-19 vaccines released by The National Academies of Sciences, Engineering and Medicine proposes...
BioCentury | May 26, 2020
Distillery Therapeutics

Blocking inhibitor of apoptosis proteins in liver cells to treat malaria

DISEASE CATEGORY: Infectious disease INDICATION: Malaria Targeting IAP, a family of apoptosis-blocking proteins that includes BIRC2 and BIRC3, could treat malaria by clearing liver infection. In mice infected with Plasmodium berghei sporozoites, the parasite stage...
BioCentury | May 20, 2020
Product Development

Daily chart: comparing monkey data from COVID-19 vaccines

...load seven days after challenge when tested via nose swab. Theoretically, the monkeys could still transmit...
BioCentury | Apr 17, 2020
Product Development

Seeking safe microbiome therapies amid COVID-19 crisis

Reports that the novel coronavirus lingers in the stools of COVID-19 patients has put a spotlight on the safety risks of gut microbiome therapies. As researchers sort out whether the virus is capable of fecal...
BioCentury | Apr 9, 2020
Product Development

April 8 COVID-19 roundup: National Academy of Sciences says COVID-19 could continue through summer; plus HHS, SAb-CSL, Vanda-UIC, Avacta-Cytiva and more

...consultation found that while “there is some evidence to suggest that the COVID-19 virus may transmit...
Items per page:
1 - 10 of 390
BioCentury | Jan 21, 2021
Product Development

The evolving zeitgeist of COVID-19 testing

Becoming an essential pillar of the pandemic response has pushed the diagnostics industry toward more rapid and decentralized technologies, with a greater focus on routine asymptomatic screening. One year...
BioCentury | Nov 17, 2020
Product Development

Moderna times & China’s future: a BioCentury podcast

...sterilizing immunity, which is to say that somebody who gets vaccinated then can no longer transmit...
BioCentury | Oct 7, 2020
Product Development

Antigen tests outshine PCR at predicting who can transmit SARS-CoV-2

A new study finds antigen tests for COVID-19 do a better job of predicting which patients are infectious than PCR tests, even though the latter tend to be more sensitive. That conclusion, which came in...
BioCentury | Sep 19, 2020
Politics, Policy & Law

What it will take to get to mass asymptomatic screening for COVID-19

Making widespread COVID-19 screening a priority for public health will require a broad and abundant basket of testing technologies, and a coordinated plan for how to use and pay for them. The first barrier...
BioCentury | Sep 9, 2020
Product Development

NIH’s Pérez-Stable outlines ways biopharmas can address racial disparities in healthcare: a BioCentury audio interview

Eliseo Pérez-Stable, director of NIH’s National Institute on Minority Health and Health Disparities, says the information on racial and minority ethnic disparities in healthcare is out there, it’s...
BioCentury | Sep 2, 2020
Product Development

COVID-19 Quick Takes: NAS framework on vaccine allocation prioritizes higher risk groups

Framework to allocate vaccinesA discussion draft of a framework on equitable allocation of COVID-19 vaccines released by The National Academies of Sciences, Engineering and Medicine proposes...
BioCentury | May 26, 2020
Distillery Therapeutics

Blocking inhibitor of apoptosis proteins in liver cells to treat malaria

DISEASE CATEGORY: Infectious disease INDICATION: Malaria Targeting IAP, a family of apoptosis-blocking proteins that includes BIRC2 and BIRC3, could treat malaria by clearing liver infection. In mice infected with Plasmodium berghei sporozoites, the parasite stage...
BioCentury | May 20, 2020
Product Development

Daily chart: comparing monkey data from COVID-19 vaccines

...load seven days after challenge when tested via nose swab. Theoretically, the monkeys could still transmit...
BioCentury | Apr 17, 2020
Product Development

Seeking safe microbiome therapies amid COVID-19 crisis

Reports that the novel coronavirus lingers in the stools of COVID-19 patients has put a spotlight on the safety risks of gut microbiome therapies. As researchers sort out whether the virus is capable of fecal...
BioCentury | Apr 9, 2020
Product Development

April 8 COVID-19 roundup: National Academy of Sciences says COVID-19 could continue through summer; plus HHS, SAb-CSL, Vanda-UIC, Avacta-Cytiva and more

...consultation found that while “there is some evidence to suggest that the COVID-19 virus may transmit...
Items per page:
1 - 10 of 390